Skip to content

Incisional Negative Pressure Wound Therapy in High Risk Patients Undergoing Panniculectomy: A Prospective Randomized Controlled Trial

Incisional Negative Pressure Wound Therapy in High Risk Patients Undergoing Panniculectomy: A Prospective Randomized Controlled Trial

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03010137
Enrollment
30
Registered
2017-01-04
Start date
2015-12-31
Completion date
2019-03-13
Last updated
2020-06-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Complications Wounds, Negative Pressure Wound Therapy, Wound Healing Delayed, Incisional, Panniculectomy, Incisional Negative Pressure Wound Therapy, Incisional Vac, Wound Vac, Obese, Renal Failure, Kidney Transplant; Complications, Wound Healing Complication

Brief summary

Incisional negative pressure therapy (INPWT) has previously been shown in certain patient populations to decrease wound healing complications, decrease the rate of hematomas and seromas, as well as have better scar quality. We have found a group of patients, those who have panniculectomies in preparation for renal transplant, with significantly higher rates of wound healing complications. We believe the best way to demonstrate benefits of incisional negative pressure wound therapy will be in this group of patients known to have significantly higher rates of wound complications.

Interventions

PROCEDUREStandard Closure with Skin Glue
DEVICEPICO (Smith&Nephew)

Off the shelf, disposable negative pressure wound therapy device. Contains sterile dressing as well as an attached small (pager sized) suction device/canister.

DEVICEDermabond

Final wound closure with skin glue.

Sponsors

University of California, Davis
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* All patients undergoing panniculectomy in preparation for renal transplantation at the University of California Davis Medical Center. Patients who are entered into the trial and have 30 days of follow up, and those in the INPWT study arm who successfully complete 7 days of treatment, will be included.

Exclusion criteria

* All patients who previously demonstrated a hypersensitivity reaction to adhesives and qualify for panniculectomy in preparation for renal transplantation, or all patients who are undergoing panniculectomy for reasons other than in preparation for renal transplantation (i.e. after massive weight loss or for cosmetic reasons). Patients who do not complete the duration of treatment of negative pressure wound therapy (7 days), or patients who do not follow up for a minimum of 30 days from the date of surgery will be excluded. Adults unable to consent, infants, children, teenagers, pregnant patients and prisoners will be excluded. It is also extremely unlikely, based on our study population, that we will encounter any of these patients.

Design outcomes

Primary

MeasureTime frameDescription
Major Wound Healing ComplicationsUp to 3 months after operationAbscess, Hematoma or any wound complication requiring return to the operating room.
Minor Wound Healing ComplicationsUp to 3 months after operationCellulitis, Seroma, Superficial Wound Separation

Secondary

MeasureTime frameDescription
Time to Drain RemovalUp to 3 months after operationTime to final drain removal after the operation

Other

MeasureTime frameDescription
Scarringdata not collected due to early terminationWill assess using Vancouver Scar Scale
Pain Score Self Reported by the Patient After Surgerydata not collected due to early terminationAssess via a visual analog scale at specified intervals
Quality of Life as Measured by SF-36 Validated Surveydata not collected due to early terminationAssess via SF-36 validated survey at specified intervals

Countries

United States

Participant flow

Participants by arm

ArmCount
Standard Closure
After surgical closure is complete, the patient receives standard of care operative incision treatment (dermabond/topical skin adhesive). Standard Closure with Skin Glue Dermabond: Final wound closure with skin glue.
15
Incisional Negative Pressure Wound Therapy
After surgical closure is complete, an incisional negative pressure wound therapy device is applied to the incision in its entirety. This device is placed on the wound, sterilely, in the operating room, at the conclusion of the procedure. The incisional negative pressure wound therapy device is to remain in place for 7 days, and is removed in clinic after completion. Incisional Negative Pressure Wound Therapy PICO (Smith&Nephew): Off the shelf, disposable negative pressure wound therapy device. Contains sterile dressing as well as an attached small (pager sized) suction device/canister.
15
Total30

Baseline characteristics

CharacteristicIncisional Negative Pressure Wound TherapyTotalStandard Closure
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
2 Participants2 Participants0 Participants
Age, Categorical
Between 18 and 65 years
13 Participants28 Participants15 Participants
Age, Continuous57 years
STANDARD_DEVIATION 10
55.6 years
STANDARD_DEVIATION 12.7
54 years
STANDARD_DEVIATION 8.6
Race and Ethnicity Not Collected0 Participants
Region of Enrollment
United States
15 Participants30 Participants15 Participants
Sex: Female, Male
Female
11 Participants21 Participants10 Participants
Sex: Female, Male
Male
4 Participants9 Participants5 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 150 / 15
other
Total, other adverse events
0 / 150 / 15
serious
Total, serious adverse events
0 / 150 / 15

Outcome results

Primary

Major Wound Healing Complications

Abscess, Hematoma or any wound complication requiring return to the operating room.

Time frame: Up to 3 months after operation

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Standard ClosureMajor Wound Healing Complications5 Participants
Incisional Negative Pressure Wound TherapyMajor Wound Healing Complications3 Participants
Primary

Minor Wound Healing Complications

Cellulitis, Seroma, Superficial Wound Separation

Time frame: Up to 3 months after operation

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Standard ClosureMinor Wound Healing Complications3 Participants
Incisional Negative Pressure Wound TherapyMinor Wound Healing Complications2 Participants
Secondary

Time to Drain Removal

Time to final drain removal after the operation

Time frame: Up to 3 months after operation

ArmMeasureValue (MEAN)Dispersion
Standard ClosureTime to Drain Removal29 daysStandard Deviation 14.1
Incisional Negative Pressure Wound TherapyTime to Drain Removal24 daysStandard Deviation 13.5
Other Pre-specified

Pain Score Self Reported by the Patient After Surgery

Assess via a visual analog scale at specified intervals

Time frame: data not collected due to early termination

Population: Unable to perform final analysis due to early closure of the study

Other Pre-specified

Quality of Life as Measured by SF-36 Validated Survey

Assess via SF-36 validated survey at specified intervals

Time frame: data not collected due to early termination

Population: unable to perform final analysis due to early termination of study

Other Pre-specified

Scarring

Will assess using Vancouver Scar Scale

Time frame: data not collected due to early termination

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026